Skip to main content
Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
5.95
-0.04 (-0.67%)
At close: Apr 28, 2026, 4:00 PM EDT
5.91
-0.04 (-0.67%)
After-hours: Apr 28, 2026, 7:56 PM EDT

Plus Therapeutics Revenue

In the year 2025, Plus Therapeutics had annual revenue of $5.21M, down -10.49%. Plus Therapeutics had revenue of $1.37M in the quarter ending December 31, 2025, a decrease of -3.19%.

Revenue (ttm)
$5.21M
Revenue Growth
-10.49%
P/S Ratio
7.83
Revenue / Employee
$186,179
Employees
28
Market Cap
40.83M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20255.21M-611.00K-10.49%
Dec 31, 20245.82M911.00K18.54%
Dec 31, 20234.91M4.69M2,093.30%
Dec 31, 2022224.00K--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Atara Biotherapeutics 120.77M
Aligos Therapeutics 2.19M
Werewolf Therapeutics 1.14M
RenovoRx 1.12M
Mereo BioPharma Group 500.00K
INmune Bio 50.00K
Revenue Rankings

PSTV News

More News